Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
46,048,315
-
Share change
-
+6,194,370
-
Total reported value
-
$898,408,712
-
Put/Call ratio
-
159%
-
Price per share
-
$19.50
-
Number of holders
-
167
-
Value change
-
+$119,962,110
-
Number of buys
-
84
-
Number of sells
-
63
Institutional Holders of AMAG PHARMACEUTICALS INC - COMMON STOCK (AMAG) as of Q2 2018
As of 30 Jun 2018,
AMAG PHARMACEUTICALS INC - COMMON STOCK (AMAG) was held by
167 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
46,048,315 shares.
The largest 10 holders included
BlackRock Inc., Palo Alto Investors LP, VANGUARD GROUP INC, STATE STREET CORP, Jackson Square Partners, LLC, Camber Capital Management LP, ARMISTICE CAPITAL, LLC, FMR LLC, RENAISSANCE TECHNOLOGIES LLC, and JPMORGAN CHASE & CO.
This page lists
167
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.